Eczema Newswire (Page 3)

Eczema Newswire (Page 3)

Comprehensive Real-Time News Feed for Eczema. (Page 3)

Results 41 - 60 of 255 in Eczema

  1. Phototherapy Mask Market 2017 Global Overview, Research, in-Depth...Read the original story w/Photo

    Jun 16, 2017 | SBWire

    ... To treat hyperbilirubinemia and jaundice in newborn babies by skin thermistor under fluorescent light To treat eczema by narrowband ultraviolet B-light, which is commonly found in children with symptoms such as dry itchy red skin followed by ...

    Comment?

  2. When Treating Eczema in Babies, the 'Wet Look' is InRead the original story w/Photo

    Jun 14, 2017 | Health News Digest

    New York, NY, June 14, 2017 - The "wet look" is in. At least, that seems to be the case for treating the delicate skin of babies who have eczema, according to dermatologist, Valerie Goldburt, MD, PhD, with Advanced Dermatology PC.

    Comment?

  3. When Treating Eczema in Babies, the "Wet Look" is InRead the original story w/Photo

    Jun 14, 2017 | PRWeb

    Dermatologist Valerie Goldburt, MD, PhD with Advanced Dermatology PC Advises Parents Good Skin Care is Critical in Managing This Complex Skin Disorder; Offers Treatment Tips Referred to as atopic dermatitis, eczema is a rash that makes the skin dry, scaly, and itchy. It frequently forms on the scalp or face, particularly on the cheeks.

    Comment?

  4. Leslie Beck: Is apple cider vinegar a miracle health product?Read the original story w/Photo

    Jun 9, 2017 | The Globe and Mail

    ... the vinegar is also touted to prevent constipation, ease arthritic joints, reduce heartburn, banish acne and treat eczema, among numerous other things. That's a whole lot of health benefits. But here's the deal: Most claims are untested and, ...

    Comment?

  5. UPM Scientists Produce Steroid-Free Cream To Treat EczemaRead the original story

    Jun 7, 2017 | Malaysian National News Agency

    Good news for those who are suffering from eczema, as a group of scientists from Universiti Putra Malaysia has produced a steroid-free ultra moisturising natural cream to treat the problem. The cream, REMDII Sensitive, was generated through research efforts undertaken by the university's five scientists and biomedical experts since 2013.

    Comment?

  6. Why Regeneron Is Quickly Becoming My Top Biotech Stock PickRead the original story w/Photo

    Jun 5, 2017 | The Motley Fool

    ... triple levels from the same quarter in 2016. Dupixent is the second of its new drugs to score a FDA green light. The eczema drug inhibits interleukin-4 and interleukin-13, two anti-inflammatory proteins that can lead to eczema, a condition that ...

    Comment?

  7. What's Behind Regeneron's Big 15% Bounce in May?Read the original story w/Photo

    Jun 2, 2017 | The Motley Fool

    After a solid sales launch for the company's new eczema drug and a Food and Drug Administration approval for its new rheumatoid arthritis drug on May 22, shares of Regeneron Pharmaceuticals The launch of Dupixent and the approval of Kevzara are important milestones for Regeneron Pharmaceuticals, a big-cap biotech that's long relied heavily on its top-selling age-related macular degeneration drug Eylea for revenue. On May 4, management reported first-quarter financial results and updated investors on its progress in rolling out Dupixent, which was approved by the FDA in April.

    Comment?

  8. Dermatitis and Eczema Essential Oil BlendRead the original story

    Jun 2, 2017 | Natural Holistic Health

    ... was to test and confirm the efficacy and safety of high quality Tea Tree Oil. The 4 patients with Dermatitis and eczema were cured or showed remarkable improvement of their conditions. In this case, both Tea Tree Oil and a Tea Tree Oil cream were ...

    Comment?

  9. Can These 3 High-Flying Healthcare Stocks Reach the Clouds?Read the original story

    May 23, 2017 | Fox News

    ... but years of investment in research and development of new medicines has begun to bear fruit. For example, canine eczema treatment Cytopoint became the first biologic drug to earn FDA approval for treatment of pets last December. Cytopoint and other ...

    Comment?

  10. FDA approves Sanofi Genzyme rheumatoid arthritis drugRead the original story w/Photo

    May 22, 2017 | Boston.com

    ... In late March, the Food and Drug Administration gave a green light to the company's medicine to treat severe forms of eczema. The FDA approved Kevzara for adult patients with moderately to severely active rheumatoid arthritis who have not responded ...

    Comment?

  11. Top 3 Trends Impacting the Global Health and Wellness Food Market Through 2021: TechnavioRead the original story w/Photo

    May 22, 2017 | Information Technology

    ... energy and improve breath by destroying candida. They also improve skin health since probiotics naturally treat eczema and psoriasis and help heal leaky gut syndrome and inflammatory bowel disease. The demand for probiotic products will propel the ...

    Comment?

  12. View Press ReleaseRead the original story w/Photo

    May 22, 2017 | Business Wire

    ... energy and improve breath by destroying candida. They also improve skin health since probiotics naturally treat eczema and psoriasis and help heal leaky gut syndrome and inflammatory bowel disease. The demand for probiotic products will propel the ...

    Comment?

  13. Sanofi pegs U.S. drug price rises to below healthcare inflationRead the original story w/Photo

    Oct 30, 2014 | Reuters

    ... in 2013. The company surprised many investors in March when it set a lower-than-expected price for its new injectable eczema drug Dupixent, developed with long-time partner Regeneron Pharmaceuticals ( But it has been accused by a group of patients ...

    Comment?

  14. Spring allergy season is also a bad time for eczema sufferersRead the original story w/Photo

    May 8, 2017 | New York Daily News

    Many of us associate spring with sniffling and itching, but one group of patients faces the season with particular dread - people with eczema, a set of chronic skin conditions that cause itchy red lesions. For patients with mild cases, the warmer temperatures can trigger flare-ups.

    Comment?

  15. Researchers reveal allergies may be linked to eczemaRead the original story w/Photo

    May 6, 2017 | NewsTarget.com

    Researchers infer that allergy and eczema may go hand in hand, and stress that understanding the connection between the two conditions may mitigate the risk of suffering from the latter. "It is important for both patients and healthcare professionals to understand the connection between atopic eczema and allergy.

    Comment?

  16. Eczema Treatment Market Research Report - Future Demand and Growth Analysis with Forecast 2025Read the original story w/Photo

    May 5, 2017 | SBWire

    Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness.

    Comment?

  17. British stocks lag Europe as miners, retailer Next sinkRead the original story w/Photo

    May 4, 2017 | Reuters

    ... industry consolidation paragraph 13, updates stock prices, paragraph 5) May 4 Regeneron Pharmaceuticals Inc said its eczema drug Dupixent was off to a strong start and the biotech stood by its full-year sales forecast for its flagship drug Eylea ...

    Comment?

  18. UPDATE 4-As Eylea fears fade, focus turns to Regeneron's eczema drugRead the original story w/Photo

    May 4, 2017 | Reuters

    ) said its eczema drug Dupixent was off to a strong start and the biotech stood by its full-year sales forecast for its flagship drug Eylea even as competition heats up. Regeneron is betting on two key treatments - sarilumab, to treat rheumatoid ...

    Comment?

  19. UPDATE 3-As Eylea fears fade, focus turns to Regeneron's eczema drugRead the original story w/Photo

    May 4, 2017 | Reuters

    May 4 Regeneron Pharmaceuticals Inc stood by its full-year sales forecast for its flagship drug Eylea and said the early adoption of its eczema drug Dupixent was encouraging, easing concerns about the company's reliance on Eylea as competition heats up. Regeneron's shares jumped nearly 6 percent to $430.93 on Thursday, rising for the fifth day in a row to touch levels last seen in November.

    Comment?

  20. BRIEF-Interactive Entertainment China Cultural Technology Investments says unit entered into SPARead the original story w/Photo

    May 4, 2017 | Reuters

    ... Inc stood by its full-year sales forecast for its flagship drug Eylea and said the early adoption of its eczema drug Dupixent was encouraging, easing concerns about the company's reliance on Eylea as competition heats up. DAKAR, May 4 (Thomson ...

    Comment?